RENAL: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
RENAL
Largest movements
- Tangible fixed assets -€14,334
down €14,334 (-2.8%), from €511,474 to €497,140
of which Land and buildings: -€10,337
- Cash -€11,112
down €11,112 (-20.0%), from €55,499 to €44,387
mainly Net result for the year (-€24,692) and Trade debts (-€5,186)
- Profit (loss) carried forward -€24,692
down €24,692 (-543%), from -€4,548 to -€29,240
- Gross operating margin -€28,468
down €28,468, from €23,995 to -€4,473
- Depreciation -€368
down €368 (-2.5%), from €14,702 to €14,334
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €575,783 | €546,204 | -€29,579 | -5.1% |
| Fixed assets | 21/28 | €511,474 | €497,140 | -€14,334 | -2.8% |
| Tangible fixed assets | 22/27 | €511,474 | €497,140 | -€14,334 | -2.8% |
| Land and buildings | 22 | €486,693 | €476,356 | -€10,337 | -2.1% |
| Plant, machinery and equipment | 23 | €14,856 | €11,925 | -€2,931 | -19.7% |
| Other tangible fixed assets | 26 | €9,925 | €8,860 | -€1,065 | -10.7% |
| Current assets | 29/58 | €64,309 | €49,063 | -€15,245 | -23.7% |
| Amounts receivable within one year | 40/41 | €7,317 | €2,648 | -€4,669 | -63.8% |
| Trade receivables | 40 | €5,676 | - | -€5,676 | |
| Other amounts receivable | 41 | €1,641 | €2,648 | +€1,007 | +61.4% |
| Cash at bank and in hand | 54/58 | €55,499 | €44,387 | -€11,112 | -20.0% |
| Deferred charges and accrued income | 490/1 | €1,493 | €2,028 | +€535 | +35.8% |
| Total equity and liabilities | 10/49 | €575,783 | €546,204 | -€29,579 | -5.1% |
| Equity | 10/15 | €568,383 | €543,691 | -€24,692 | -4.3% |
| Contributions | 10/11 | €572,752 | €572,752 | = | 0.0% |
| Reserves | 13 | €179 | €179 | = | 0.0% |
| Non-distributable reserves | 130/1 | €179 | €179 | = | 0.0% |
| Reserves not available under the articles | 1311 | €179 | €179 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€4,548 | -€29,240 | -€24,692 | -543% |
| Amounts payable | 17/49 | €7,399 | €2,513 | -€4,887 | -66.0% |
| Amounts payable within one year | 42/48 | €6,549 | €1,363 | -€5,186 | -79.2% |
| Trade debts | 44 | €5,549 | €363 | -€5,186 | -93.5% |
| Suppliers | 440/4 | €5,549 | €363 | -€5,186 | -93.5% |
| Other amounts payable | 47/48 | €1,000 | €1,000 | = | 0.0% |
| Accrued charges and deferred income | 492/3 | €850 | €1,150 | +€300 | +35.3% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €14,702 | €14,334 | -€368 | -2.5% |
| Other operating charges | 640/8 | €5,670 | €5,843 | +€173 | +3.0% |
| Gross operating margin | 9900 | €23,995 | -€4,473 | -€28,468 | |
| Operating profit (loss) | 9901 | €3,623 | -€24,649 | -€28,272 | |
| Financial charges | 65/66B | €47 | €43 | -€4 | -7.6% |
| Recurring financial charges | 65 | €47 | €43 | -€4 | -7.6% |
| Profit (loss) for the period before taxes | 9903 | €3,576 | -€24,692 | -€28,269 | |
| Profit (loss) for the period | 9904 | €3,576 | -€24,692 | -€28,269 | |
| Profit (loss) for the period to be appropriated | 9905 | €3,576 | -€24,692 | -€28,269 |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 26 October 2026 via checked.be.